ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,164.12
-0.19%
Dow Jones
39,118.86
-0.12%
Gold vs US Dollar
2,326.73
0.00%
Brent Oil
84.85
0.00%
Bitcoin
61,622.65
1.20%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Vascular Biogenics Ltd (VBLT)

  7. Vascular Biogenics Ltd (VBLT) News

Vascular Biogenics (VBLT)

Vascular Biogenics Ltd
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:VBLT
DateTimeSourceHeadlineSymbolCompany
20/06/202422:01Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:VBLTVascular Biogenics Ltd
10/05/202422:18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VBLTVascular Biogenics Ltd
10/05/202422:17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VBLTVascular Biogenics Ltd
10/05/202422:12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VBLTVascular Biogenics Ltd
10/05/202422:07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VBLTVascular Biogenics Ltd
10/05/202422:06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VBLTVascular Biogenics Ltd
10/05/202422:04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VBLTVascular Biogenics Ltd
06/05/202421:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VBLTVascular Biogenics Ltd
19/04/202421:56Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:VBLTVascular Biogenics Ltd
12/04/202413:44Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VBLTVascular Biogenics Ltd
11/04/202422:00Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:VBLTVascular Biogenics Ltd
09/04/202422:20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VBLTVascular Biogenics Ltd
08/04/202417:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VBLTVascular Biogenics Ltd
01/04/202421:30Edgar (US Regulatory)Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405NASDAQ:VBLTVascular Biogenics Ltd
25/03/202413:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VBLTVascular Biogenics Ltd
22/02/202413:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VBLTVascular Biogenics Ltd
22/02/202413:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VBLTVascular Biogenics Ltd
16/02/202414:00Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:VBLTVascular Biogenics Ltd
05/02/202422:00Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:VBLTVascular Biogenics Ltd
02/02/202421:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VBLTVascular Biogenics Ltd
26/01/202416:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VBLTVascular Biogenics Ltd
26/01/202416:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VBLTVascular Biogenics Ltd
26/01/202416:04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VBLTVascular Biogenics Ltd
26/01/202416:04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VBLTVascular Biogenics Ltd
26/01/202416:02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VBLTVascular Biogenics Ltd
11/01/202422:22Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:VBLTVascular Biogenics Ltd
08/01/202421:21Edgar (US Regulatory)Form RW - Registration Withdrawal RequestNASDAQ:VBLTVascular Biogenics Ltd
03/01/202422:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VBLTVascular Biogenics Ltd
02/01/202422:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VBLTVascular Biogenics Ltd
28/12/202322:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VBLTVascular Biogenics Ltd
 Showing the most relevant articles for your search:NASDAQ:VBLT

Your Recent History

LSE
GKP
Gulf Keystone Petroleum
LSE
QBT
Quantum Blockchain Techn...
LSE
ENET
Ethernity Networks
LSE
GOLD
LSE
VAST
Vast Resources
LSE
LLOY
Lloyds Banking
LSE
POS
Plexus
LSE
GDR
Genedrive
LSE
RKH
Rockhopper Exploration
LSE
AAZ
Anglo Asian Mining
LSE
HE1
Helium One Global
LSE
TERN
Tern
LSE
ANGS
Angus Energy
LSE
IGG
Ig
LSE
CHLL
Chill Brands
LSE
ALBA
Alba Mineral Resources
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved